trials.ai

leverages artificial intelligence to efficiently navigate research teams in designing clinical trials that help sponsors to get treatments to patients, faster.

[trials.ai @trialsAI]

Ready to accelerate your Drug Development efforts? https://t.co/kzjCcySHb7 by @ZSAssociates is at #DPharm2023 to discuss cutting-edge approaches to Study Design intelligence and automation. Swing by booth 20 to join the conversation + unlock possibilities. 🔬💪 #InnovateWithUs

[trials.ai @trialsAI]

We couldn't have reached this exciting milestone without the incredible support of our @nexcubed family!

[Nex Cubed @nexcubed]

Congrats to Nex Cubed portfolio company, @trialsAI, for their recent acquisition! The female founded and led company leverages artificial intelligence to optimize clinical trial protocols for speed and success. Excited to see where your journey takes you next!

[trials.ai @trialsAI]

Friends, we have some exciting news to share :)

[ZS @ZSAssociates]

ZS is acquiring @trialsAI as part of our effort to help clinical development teams optimize study designs for speed while improving the participant experience. Learn how we can help transform your studies and speed up your time to market: https://t.co/qjIvzGJubG

[Daniel Haders II PhD @DJHadersPhD]

@BrittanyMeiling @sdut @JonathanWosen Welcome, Jonathan! Looking forward to ur reporting. Our investment team @nexcubed & @swayventures is supporting the digitization of biotech w/ San Diego firms like https://t.co/YMvdP4p54C & @trialsAI as well as firms like @MedCrypt https://t.co/U2Pnh4oLam Skillpower

[trials.ai @trialsAI]

Can someone please suggest a bank that takes care of ALL of their customers? #bankofamerica will be losing our business after today's #PaycheckProtectionPlan fiasco. BTW - we don't have a CC with #BoA because their offerings paled in comparison to @brexcard for startups.

[trials.ai @trialsAI]

@AndyBiotech Our hearts go out to his family and friends. May they all find peace in this time of sorrow.

[Sway Capital @sway_capital]

AI software is critical to the biomedical research landscape, @trialsAI accelerates the recruitment process making it easier for patients to enroll and engage or by analyzing medical records to identify more patients suitable for a specific trial. https://t.co/ez6T2YI6Ft

[trials.ai @trialsAI]

@FinancialsOnTap https://t.co/iR1mJHq5DS

[Sway Capital @sway_capital]

Pharma Needs to Go Big on Artificial Intelligence: If #AI can be used to predict better responders to a therapy, it can lead to better patient recruitment leading to more efficient trials. @trialsAI https://t.co/zTlmXamRzD

[Fresh Brewed Tech - SD Tech News @freshbrewedtech]

Our latest @TacosAndTechPod guest is Kim Walpole, co-founder & CEO of @trialsAI. Listen in to hear about her entrepreneurial journey as well as her favorite local eats and brews 🌮 Soundcloud: https://t.co/uj6TGzTvJT | Everywhere else: https://t.co/zKhNLyIrLb

[trials.ai @trialsAI]

Looking forward to joining @nexcubed & @swayventures during #jpm2020 #BioWeekSF for an exciting talk about creating the future of #digitalhealth

[Daniel Haders II PhD @DJHadersPhD]

Nex Cubed & Sway Ventures in partnership w/ Boehringer Ingelheim Ventures, Aptar & The AAIH are bringing together VC's, CVC's, C-Suite HC leaders & entrepreneurs to ask one question: How do we Create the Future of #DigitalHealth at #JPM20. #BioWeekSF

https://t.co/IvlFEE07jO

[trials.ai @trialsAI]

The Biocom Big Data Summit is today! Our Chief Scientist @DavidBFogel & CEO @kimbeela will each be taking the stage. More here: https://t.co/NtZ4CkUqI1

[trials.ai @trialsAI]

"When designing a trial, researchers lean on information from numerous sources ... AI-powered software can not only process all of that information faster... “It just screams as being an opportunity to use AI,” Lipset says https://t.co/HO7GcOKdWT

[trials.ai @trialsAI]

Excited to share the exciting things we're doing to help researchers get treatments to patients, faster!

[Connect @CONNECTinSD]

@trialsAI is re-imagining how clinical trials are researched & planned. Their Smart Protocol solution leverages technology to intelligently guide research teams through designing clinical trials. Hear their pitch @ Venture Summit Thurs https://t.co/E6AyBNpeb6 #InvestSD #ConnectSD

[trials.ai @trialsAI]

@egaly to researchers re: diversity in clinical trials - "The best way to move forward in recruitment and retention is to be less weird" #DPharm2019

[Joe Dustin @eclinical]

Another sighting of @AndreaCoravos and #andysslide. https://t.co/elKz2oIExb presenting at Dpharm Idol. #DPharm2019

[trials.ai @trialsAI]

Can't wait to learn more about these exciting companies! #DPharm2019

[The Conference Forum @ConferenceForum]

DPharm Idol Disrupt is about to start! We're going to hear from @TrialScout #xCures @ShimmerResearch @IntelligenciaAI @trialsAI @TassoInc #DPharm2019

[trials.ai @trialsAI]

Tufts' Ken Getz asking an important question: why aren't we giving trial participants their results? #DPharm2019

[trials.ai @trialsAI]

@LuijpersSarah call to action: rethink trial design #DPharm2019 @allergan

[trials.ai @trialsAI]

@ScottGottliebMD "in many cases the way we're measuring clinical benefit are outdated" #DPharm2019